A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee

NCT01873053 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: WIN-34B
DRUG: Placebo

Sponsor

Kyunghee University Medical Center

Collaborators

[object Object]
[object Object]